What is ZEA Biosciences?
ZEA Biosciences is a Boston-based biopharmaceutical innovator that integrates biological science with advanced data analytics to enhance plant growth cycles and develop high-value medicinal plant products. The company's proprietary Zea Lighthouse plant biotechnology platform is engineered to identify, cultivate, and produce potent natural compounds and plant-based biologics, aiming to revolutionize global disease treatment paradigms. By forging collaborations with leading academic institutions and research agencies, Zea Biosciences validates novel molecular discoveries that contribute to improved human health outcomes. Their core mission revolves around harnessing the therapeutic potential of plants to foster healthier communities and broaden access to cost-effective medicines.
How much funding has ZEA Biosciences raised?
ZEA Biosciences has raised a total of $146K across 1 funding round:
Debt
$146K
Debt (2021): $146K with participation from PPP
Key Investors in ZEA Biosciences
PPP
Public-Private Partnership
What's next for ZEA Biosciences?
The substantial late-stage funding indicates ZEA Biosciences is poised for significant operational expansion and market penetration. This capital injection is likely to accelerate the commercialization of its plant-based biologics and natural compounds, potentially leading to new therapeutic offerings. Strategic investments at this stage often signal a focus on scaling production, expanding clinical trials, and strengthening market presence. ZEA Biosciences' commitment to leveraging plant biotechnology for medicinal purposes suggests a future focused on addressing unmet medical needs and enhancing global healthcare accessibility.
See full ZEA Biosciences company page
